Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (51-60 of 522) with videos related to

Pageof 53
Sort By:
European Urology|January 14, 2016
Words of Wisdom. Re: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant MelanomaGregory E Tasian, Matthew R Cooperberg
Brachytherapy|August 8, 2015
Point: Surgery is the most cost-effective option for prostate cancer needing treatmentAhmed A Hussein, Matthew R Cooperberg
Brachytherapy|August 10, 2015
Rebuttal to Drs. Markovina and MichalskiAhmed A Hussein, Matthew R Cooperberg
JAMA|November 9, 2015
Treatment Trends for Prostate Cancer--ReplyMatthew R Cooperberg, Peter R Carroll
JAMA|July 8, 2015
Trends in Management for Patients With Localized Prostate Cancer, 1990-2013Matthew R Cooperberg, Peter R Carroll
Current Opinion in Urology|April 10, 2009
Management of localized prostate cancer in men over 65 yearsMatthew R Cooperberg, Badrinath R Konety
Cancer Treatment and Research|September 1, 2018
Prostate Cancer MarkersAdam J Gadzinski, Matthew R Cooperberg
World Journal of Urology|May 17, 2017
Epidemiology of prostate cancerMatthew R Cooperberg, June M Chan
Urology|July 4, 2012
Editorial commentMatthew R Cooperberg, June M Chan
The Journal of Urology|September 18, 2007
Trends in regionalization of inpatient care for urological malignancies, 1988 to 2002Matthew R Cooperberg, Sanjukta Modak, Badrinath R Konety
Pageof 53

Showing results (51-60 of 522) with videos related to

Sort By:
Pageof 53
European Urology|January 14, 2016
Words of Wisdom. Re: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant MelanomaGregory E Tasian, Matthew R Cooperberg
Brachytherapy|August 8, 2015
Point: Surgery is the most cost-effective option for prostate cancer needing treatmentAhmed A Hussein, Matthew R Cooperberg
Brachytherapy|August 10, 2015
Rebuttal to Drs. Markovina and MichalskiAhmed A Hussein, Matthew R Cooperberg
JAMA|November 9, 2015
Treatment Trends for Prostate Cancer--ReplyMatthew R Cooperberg, Peter R Carroll
JAMA|July 8, 2015
Trends in Management for Patients With Localized Prostate Cancer, 1990-2013Matthew R Cooperberg, Peter R Carroll
Current Opinion in Urology|April 10, 2009
Management of localized prostate cancer in men over 65 yearsMatthew R Cooperberg, Badrinath R Konety
Cancer Treatment and Research|September 1, 2018
Prostate Cancer MarkersAdam J Gadzinski, Matthew R Cooperberg
World Journal of Urology|May 17, 2017
Epidemiology of prostate cancerMatthew R Cooperberg, June M Chan
Urology|July 4, 2012
Editorial commentMatthew R Cooperberg, June M Chan
The Journal of Urology|September 18, 2007
Trends in regionalization of inpatient care for urological malignancies, 1988 to 2002Matthew R Cooperberg, Sanjukta Modak, Badrinath R Konety
Pageof 53